Spectrum Health Primary Care Partners
Spectrum Health Primary Care Partners was paid $14.49M by Medicaid between Jan 2018 and Dec 2024, across 77 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 40% of everything it billed.
GRAND RAPIDS, MI 49548
Next to other Emergency Medicine Physician providers in Michigan
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 43,863 | $1.37M | |
| 2019 | 43,804 | $1.56M | |
| 2020 | 34,533 | $1.26M | |
| 2021 | 50,402 | $1.97M | |
| 2022 | 67,592 | $2.67M | |
| 2023 | 80,537 | $3.03M | |
| 2024incomplete | 62,720 | $2.62M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 40% | 119,151 | 112,932 | $5.79M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 64,605 | 62,020 | $4.01M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 17% | 39,908 | 39,703 | $2.40M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.9% | 4,595 | 4,588 | $417K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.7% | 30,472 | 29,972 | $397K |
| 87428 | 1.6% | 6,330 | 6,283 | $228K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.6% | 7,981 | 7,911 | $228K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.2% | 4,401 | 4,352 | $176K |
| 12001 | <1% | 1,775 | 1,755 | $91K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 9,893 | 8,716 | $83K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,745 | 2,995 | $77K |
| 81025 | <1% | 11,089 | 10,875 | $74K |
65 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,984 | $57K |
| 10060 | <1% | 726 | $48K | |
| 81003 | <1% | 26,325 | $46K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 5,431 | $39K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 435 | $39K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,178 | $35K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,705 | $28K |
| 12011 | <1% | 335 | $21K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,398 | $20K |
| 90715 | <1% | 684 | $20K | |
| 73630 | <1% | 1,257 | $17K | |
| 73610 | <1% | 1,142 | $16K | |
| 69209 | <1% | 1,440 | $14K | |
| 73130 | <1% | 770 | $11K | |
| 90686 | <1% | 454 | $8K | |
| 82947 | <1% | 3,121 | $8K | |
| 73140 | <1% | 453 | $8K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,619 | $7K |
| 73110 | <1% | 442 | $7K | |
| 90714 | <1% | 314 | $7K | |
| 12002 | <1% | 97 | $6K | |
| 86308 | <1% | 1,226 | $5K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,821 | $5K |
| 0064A | <1% | 124 | $4K | |
| 0001A | <1% | 106 | $4K | |
| 0002A | <1% | 104 | $4K | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 591 | $3K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 566 | $3K |
| 0031A | <1% | 63 | $2K | |
| 91322 | <1% | 20 | $2K | |
| 29125 | <1% | 68 | $2K | |
| 90739 | <1% | 13 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,826 | $2K |
| 73562 | <1% | 103 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,750 | $2K |
| 90480 | <1% | 34 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 101 | $1K |
| 90656 | <1% | 53 | $1K | |
| 73030 | <1% | 84 | $1K | |
| 0004A | <1% | 20 | $759.15 | |
| 84703 | <1% | 110 | $635.60 | |
| 0054A | <1% | 17 | $562.95 | |
| 0124A | <1% | 14 | $488.74 | |
| 0052A | <1% | 14 | $451.75 | |
| 0011A | <1% | 13 | $381.08 | |
| 90688 | <1% | 17 | $285.62 | |
| 73080 | <1% | 12 | $175.84 | |
| 86580 | <1% | 25 | $150.78 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 3,122 | $133.49 |
| 15853 | <1% | 14 | $94.76 | |
| 36416 | <1% | 1,534 | $90.36 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,072 | $68.58 |
| 82962 | <1% | 24 | $65.12 | |
| 81002 | <1% | 15 | $15.80 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 13 | $15.65 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 16 | $4.58 |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 0% | 1,933 | $0.00 |
| 91301 | 0% | 43 | $0.00 | |
| 1036F | 0% | 22 | $0.00 | |
| 3017F | 0% | 18 | $0.00 | |
| 91303 | 0% | 61 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 68 | $0.00 |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 43 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 47 | $0.00 |
| 91300 | 0% | 256 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Spectrum Health Primary Care Partners | Grand Rapids, MI | $219.58M |
| Newaygo County General Hospital Association | Fremont, MI | $26.99M |
| Spectrum Health Primary Care Partners | Grand Rapids, MI | $2.34M |
| Mecosta County Medical Center | Big Rapids, MI | $1.55M |
| Lakeland Community Hospital Watervliet | Watervliet, MI | $910K |
| Newaygo County General Hospital Association | Fremont, MI | $841K |
| Pennock Hospital | Hastings, MI | $719K |
| Spectrum Health Primary Care Partners | Muskegon, MI | $710K |
| Spectrum Health Primary Care Partners | Holland, MI | $319K |
| Memorial Medical Center of West Michigan | Ludington, MI | $268K |
| Spectrum Health Primary Care Partners | Hudsonville, MI | $152K |
| Reed City Hospital Corporation | Reed City, MI | $115K |
| Spectrum Health Primary Care Partners | Wyoming, MI | $106K |
| Spectrum Health Primary Care Partners | Grand Rapids, MI | $73K |
| Zeeland Community Hospital | Zeeland, MI | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.